Earnix, the Category Leader in Dynamic AI for the Insurance Industry, Acquires Zelros to Transform Insurers’ Business Performance
29.4.2025 14:10:00 CEST | Business Wire | Press Release
Earnix, the leading Dynamic AI platform for Insurance, today announced that it has signed a definitive agreement to acquire Zelros, a pioneer in Generative AI for insurers and banks. This innovative collaboration will bring the power of predictive, generative, and agentic AI across the entire risk decisioning, personalization, and claims cycle, thereby enabling pricing and underwriting professionals to deliver compelling offers while improving business performance.
By combining Earnix’s advanced Predictive AI platform with Zelros’s GenAI recommendations engine, providers can now present the right offer, at the right price, at the right time. The joint offering provides precise decision-making at scale in regulated environments for pricing and product managers, underwriters, and agents, ultimately resulting in higher conversion rates with better customer engagement and satisfaction.
Both companies bring demonstrated impact in supporting leading insurers and banks across the globe, including Aviva, AXA, BPCE, IAG, Generali, Matmut, Santander, and Tokio Marine. "As a mutual customer of Zelros and Earnix, we’re excited about the acquisition,” shared Stéphane Muller (Chief Insurance Officer) and David Quantin (Chief Information Officer) of Matmut. “The synergies between the two are compelling and will help us better meet our members' coverage needs and experiences."
"We are pleased to announce Earnix’s acquisition of Zelros, a strategic move that reaffirms us as the technology leader driving responsible AI innovation,” cited Robin Gilthorpe, CEO of Earnix. “Furthermore, we are strengthening our presence in France by establishing a key development center for the company in this critical market. We are excited about this new chapter and the immense potential it unlocks for our customers and partners."
“With the integration of our leading predictive and generative AI capabilities, we aim to reshape the customer experience by providing personalized, data-driven interactions that build confidence and drive retention,” added Damien Philippon, Co-founder and CEO of Zelros. “Our shared commitment to continuous innovation ensures that together, Earnix and Zelros will lead the way in delivering best-in-class solutions for the insurance and banking sectors.”
Dr. Erel Margalit, the Chairman of Earnix and multiple other innovative companies, including, formerly, CyberArk (Nasdaq: CYBR), says “Over the last few years, Earnix has established itself as the preeminent AI platform for Pricing, Rating, and Insurance Operations across more than 35 countries. Working with core systems providers, such as Guidewire, Earnix is the complementary AI platform which allows for dynamic, data-driven responses to changing market conditions. France has been a key focus for us as we expand our European operations, and we are delighted to have Zelros and the team join us in Paris.”
Earnix and Zelros are committed to reshaping the future, driving innovation that delivers business impact. This acquisition represents a significant leap forward in harnessing the full power of AI designed specifically to meet the evolving demands of insurers, banks, and the customers they serve.
About Earnix
Earnix is the premier provider of mission-critical, intelligent decisioning across pricing, underwriting, rating, and product personalization. Its fully integrated platform provides ultra-fast ROI and is designed to transform how global insurers and banks are run by unlocking value across all facets of the business. Earnix has been innovating for insurers and banks since 2001, with customers in over 35 countries across six continents and offices in the Americas, Europe, Asia Pacific, and Israel. Earnix is backed by investors JVP and Insight Partners.
To learn more, visit: www.earnix.com.
About Zelros
Zelros is a pioneer and award-winning InsurTech. Its GenAI-driven recommendation engine is transforming insurance distribution by enabling a unique customer and agent experience through hyper-personalized insurance recommendations across channels. Zelros is trusted by some of the world’s largest insurance companies, including AXA, BPCE, Groupe Prévoir, MAIF, and Matmut, to help them stay competitive, boost client acquisition and satisfaction, and adhere to Responsible AI governance.
More information on: www.zelros.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20250429126257/en/
Contacts
Media Relations, Earnix
press@earnix.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Andersen Consulting Strengthens Digital Transformation Capabilities with Weexa30.4.2026 15:30:00 CEST | Press Release
Andersen Consulting enters into a Collaboration Agreement with Weexa, a global provider of digital transformation, B2B integration, and supply chain digitalization solutions. Headquartered in France, Weexa delivers end-to-end services that help organizations streamline, secure, and scale their digital ecosystems. The firm specializes in B2B data-flow management and digitalization, enabling seamless communication between applications both within and across organizations through technologies such as EDI, APIs, and e-invoicing. Weexa also provides SAP integration and supply chain solutions spanning warehouse and transport management, alongside strategic consulting, project delivery, and third-party application maintenance. Serving organizations across the food, retail, wholesale, logistics, transportation, automotive, healthcare, and media sectors, Weexa supports global businesses in optimizing performance while meeting evolving regulatory and digital-compliance requirements. “Collaborati
SINOVAC Files Annual Report on Form 20-F for the Fiscal Year 202430.4.2026 15:22:00 CEST | Press Release
Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2024 (the “Annual Report”) with the U.S. Securities and Exchange Commission (“SEC”). An electronic copy of the Annual Report can be accessed on SINOVAC’s investor relations website at https://www.sinovac.com/en-us/Investors and on the SEC’s website at www.sec.gov. About SINOVAC Sinovac Biotech Ltd. (SINOVAC) is a China-based global biopharmaceutical company, with a mission of “supply vaccines to eliminate human diseases”, the company specializes in the research, development, manufacturing and commercialization of vaccines and related biological products that protect against human infectious diseases. The company’s diversified portfolio includes vaccines for influenza, viral hepatitis, varicella, Hand-Foot-Mouth disease (HFMD), poliomyelitis, pneumococcal disease, et
Experian Announces Agent Trust to Power Trusted AI Driven Commerce30.4.2026 15:00:00 CEST | Press Release
Experian today announced Experian Agent Trust™, a first-of-its-kind framework that establishes a secure, verifiable link between consumers and AI agents, bringing identity, and accountability to AI-driven transactions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260430719198/en/ Experian Announces Agent Trust to Power Trusted AI Driven Commerce. As AI agents begin to search and transact autonomously, they introduce a fundamental challenge for businesses: how to trust an action when it is no longer driven by a human. Without a verified connection between humans and AI agents, autonomous commerce introduces new risks in fraud, misrepresentation, and unauthorized transactions. Experian Agent Trust addresses this challenge through a new “Know Your Agent” (KYA) framework, extending identity verification into the age of AI. The framework ensures that agent-initiated transactions are grounded in verified consumer identity. “Agen
Meet the AI-powered fan companion: TGR Haas F1 Team RaceMate powered by Infobip30.4.2026 15:00:00 CEST | Press Release
Global AI-first cloud communications platform Infobip and TGR Haas F1 team are launching ‘TGR Haas F1 Team RaceMate powered by Infobip’, an AI-powered conversational fan companion on Apple Messages for Business and WhatsApp Business Platform. Always-on and always available, it delivers race intelligence for TGR Haas F1 Team: team race intelligence, grid positions, qualifying outcomes, sprint results, and full session schedules. The AI agent tracks drivers Ollie Bearman and Esteban Ocon with their individual championship standings and performance data in conversational format. The agent draws from a knowledge base covering driver biographies, team history, and circuit data, adapting to each user's knowledge level. Every interaction begins with a schedule check, ensuring fans always know what's happening right now. It proactively surfaces relevant information, suggests next actions, and maintains conversational flow to keep every interaction effortless and engaging. Delivered in short, s
Merck Announces First Dose in Phase 3 Study with Enpatoran for Lupus Patients with Active Skin Manifestations30.4.2026 14:05:00 CEST | Press Release
Merck, a leading global science and technology company, today announced the first patient was dosed in the Phase 3 program, ELOWEN-1 (NCT07332481) and ELOWEN-2 (NCT07355218), evaluating enpatoran in people living with lupus who experience active skin manifestations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260430733656/en/ David Weinreich, Global Head of R&D and Chief Medical Officer “People living with lupus continue to face significant challenges in achieving disease control and are very often affected by itchy, painful and stigmatized skin manifestations,” said David Weinreich, Global Head of R&D, Merck. “With enpatoran, we aim to target the underlying drivers of lupus and redefine how to approach the disease by understanding both visible skin manifestations and systemic activity.” Enpatoran is an oral selective toll-like receptor (TLR) 7/8 inhibitor designed to modulate pathways central to lupus-related inflammatio
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom